Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesArgatroban use in heparin-induced thrombocytopenia
Expert Opinion in Pharmacotherapy, 07/23/08
Boggio LN et al. - Argatroban is a safe and effective treatment for HIT. In patients taking other hepatically cleared medications, lower initial doses may have to be used to avoid over-anticoagulation.
Related Articles
Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopenia
Thrombosis Research, 10/20/09
Relevance Score: 65%%
Six-Month Follow-Up of Patients With In-Hospital Thrombocytopenia During Heparin-Based Anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] Registry)
The American Journal of Cardiology, 10/28/09
Relevance Score: 46%%
Approach to Thrombocytopenia in Older Adults
Geriatrics & Aging, 11/10/09
Relevance Score: 45%%
Incidence of Thrombocytopenia in Hospitalized Patients with Venous Thromboembolism
American Journal of Medicine, 10/02/09
Relevance Score: 45%%
Prospective, Observational Study of Outcomes in Neonates With Severe Thrombocytopenia
Pediatrics, 10/28/09
Relevance Score: 44%%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
High-Resolution Flow Cytometry: a Suitable Tool for Monitoring Aneuploid Prostate Cancer Cells after TMZ and TMZ-BioShuttle Treatment
International Journal of Medical Sciences , 11/25/09
Comparative study of control selection in a national population -based case-control study: Estimating risk of smoking on cancer deaths in Chinese men
International Journal of Medical Sciences , 11/25/09
Are patients with non-muscle-invasive bladder cancer a suitable population for a lung cancer screening trial
BJU International, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor